Editorials |
From the Vascular Medicine Research Unit, Cardiovascular Division, Brigham and Womens Hospital and Harvard Medical School, Boston, Mass.
Correspondence to James K. Liao, MD, Brigham and Womens Hospital, 65 Landsdowne St, Rm 275, Cambridge, MA 02139. E-mail jliao@rics.bwh.harvard.edu
See related article, pages 299306
Key Words: cholesterol Rho kinase calcium smooth muscle contraction
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
Although elevated serum cholesterol levels and hypertension are independent risk factors for cardiovascular disease, far too often they are manifested in the same individual.1 Whether this is a coincidental finding between 2 highly prevalent risk factors or perhaps because of some mechanistic link between these 2 processes is unclear. Regardless, the concomitant treatment of hypercholesterolemia and hypertension has yielded additive and possibly synergistic reductions in cardiovascular events.2
Previous studies attempting to link hypercholesterolemia with abnormal vascular smooth muscle (SMC) contractions have focused on the endothelium. Hypercholesterolemia and atherosclerosis impair the production and/or availability of endothelium-derived NO, leading to endothelial dysfunction and abnormal vascular reactivity.35 Indeed, acute lowering of serum cholesterol with low-density lipoprotein-apheresis or with statin therapy improves endothelium-dependent relaxations.68 These findings suggest that the endothelium serves as the primary mediator of the inhibitory effect of hypercholesterolemia on vascular motor function. The direct effect of cholesterol on SMC, however, is less well understood as endothelium-independent vasorelaxations to nitroprusside are often unaltered in hypercholesterolemia or in patients with atherosclerosis.6,8,9
In the present study, Morikage et al extend the effects of cholesterol on vascular reactivity to changes in SMC contractions.10 They showed that elevated serum cholesterol levels were associated with increased calcium sensitization of SMC through the sphingosylphosphorylcholine (SPC)/Rho-kinase (ROCK)-mediated pathway in humans and rabbits. This enhanced SMC contraction was observed only with ROCK activator SPC and not with phenylephrine or potassium; was accompanied by minimal changes in intracellular calcium concentration; and was unaffected by addition of the eNOS inhibitor, NG-monomethyl-
Related Article:
Circ. Res. 2006 99: 299-306.
This article has been cited by other articles:
![]() |
M. A. Moskowitz The 2006 Thomas Willis Lecture: The Adventures of a Translational Researcher in Stroke and Migraine Stroke, May 1, 2007; 38(5): 1645 - 1651. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |